Global Irritable Bowel Syndrome (IBS) Diagnostics Market Insights, Forecast to 2028

Table Of Contents

1 Report Business Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Laboratory Tests 1.2.3 Imaging Tests 1.3 Market by Application 1.3.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals and Clinics 1.3.3 Diagnostic Centers 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Perspective (2017-2028) 2.2 Irritable Bowel Syndrome (IBS) Diagnostics Growth Trends by Region 2.2.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Irritable Bowel Syndrome (IBS) Diagnostics Historic Market Size by Region (2017-2022) 2.2.3 Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Region (2023-2028) 2.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Dynamics 2.3.1 Irritable Bowel Syndrome (IBS) Diagnostics Industry Trends 2.3.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Drivers 2.3.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Challenges 2.3.4 Irritable Bowel Syndrome (IBS) Diagnostics Market Restraints3 Competition Landscape by Key Players 3.1 Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Revenue 3.1.1 Global Top Irritable Bowel Syndrome (IBS) Diagnostics Players by Revenue (2017-2022) 3.1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue Market Share by Players (2017-2022) 3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Diagnostics Revenue 3.4 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Concentration Ratio 3.4.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Diagnostics Revenue in 2021 3.5 Irritable Bowel Syndrome (IBS) Diagnostics Key Players Head office and Area Served 3.6 Key Players Irritable Bowel Syndrome (IBS) Diagnostics Product Solution and Service 3.7 Date of Enter into Irritable Bowel Syndrome (IBS) Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans4 Irritable Bowel Syndrome (IBS) Diagnostics Breakdown Data by Type 4.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Historic Market Size by Type (2017-2022) 4.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Type (2023-2028)5 Irritable Bowel Syndrome (IBS) Diagnostics Breakdown Data by Application 5.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Historic Market Size by Application (2017-2022) 5.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2017-2028) 6.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type 6.2.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) 6.2.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2023-2028) 6.2.3 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Type (2017-2028) 6.3 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application 6.3.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) 6.3.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2023-2028) 6.3.3 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Application (2017-2028) 6.4 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country 6.4.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2017-2022) 6.4.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada7 Europe 7.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2017-2028) 7.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type 7.2.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) 7.2.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2023-2028) 7.2.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Type (2017-2028) 7.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application 7.3.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) 7.3.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2023-2028) 7.3.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Application (2017-2028) 7.4 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country 7.4.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2017-2022) 7.4.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2017-2028) 8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type 8.2.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Type (2017-2028) 8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application 8.3.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Application (2017-2028) 8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region 8.4.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2017-2028) 9.2 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type 9.2.1 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) 9.2.2 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2023-2028) 9.2.3 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Type (2017-2028) 9.3 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application 9.3.1 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) 9.3.2 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2023-2028) 9.3.3 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Application (2017-2028) 9.4 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country 9.4.1 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2017-2022) 9.4.2 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil10 Middle East & Africa 10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size (2017-2028) 10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type 10.2.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Type (2017-2028) 10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application 10.3.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Application (2017-2028) 10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country 10.4.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE11 Key Players Profiles 11.1 Commonwealth Diagnostics International 11.1.1 Commonwealth Diagnostics International Company Details 11.1.2 Commonwealth Diagnostics International Business Overview 11.1.3 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.1.4 Commonwealth Diagnostics International Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.1.5 Commonwealth Diagnostics International Recent Developments 11.2 Genova Diagnostics 11.2.1 Genova Diagnostics Company Details 11.2.2 Genova Diagnostics Business Overview 11.2.3 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.2.4 Genova Diagnostics Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.2.5 Genova Diagnostics Recent Developments 11.3 Gemelli Biotech 11.3.1 Gemelli Biotech Company Details 11.3.2 Gemelli Biotech Business Overview 11.3.3 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.3.4 Gemelli Biotech Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.3.5 Gemelli Biotech Recent Developments 11.4 Prometheus Laboratories 11.4.1 Prometheus Laboratories Company Details 11.4.2 Prometheus Laboratories Business Overview 11.4.3 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.4.4 Prometheus Laboratories Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.4.5 Prometheus Laboratories Recent Developments 11.5 Inova Diagnostics, Inc. 11.5.1 Inova Diagnostics, Inc. Company Details 11.5.2 Inova Diagnostics, Inc. Business Overview 11.5.3 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.5.4 Inova Diagnostics, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.5.5 Inova Diagnostics, Inc. Recent Developments 11.6 Biohit Oyj 11.6.1 Biohit Oyj Company Details 11.6.2 Biohit Oyj Business Overview 11.6.3 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.6.4 Biohit Oyj Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.6.5 Biohit Oyj Recent Developments 11.7 Aerodiagnostics, LLC. 11.7.1 Aerodiagnostics, LLC. Company Details 11.7.2 Aerodiagnostics, LLC. Business Overview 11.7.3 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.7.4 Aerodiagnostics, LLC. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.7.5 Aerodiagnostics, LLC. Recent Developments 11.8 Metabolic Solutions, Inc. 11.8.1 Metabolic Solutions, Inc. Company Details 11.8.2 Metabolic Solutions, Inc. Business Overview 11.8.3 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.8.4 Metabolic Solutions, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.8.5 Metabolic Solutions, Inc. Recent Developments 11.9 Sysmex Corporation 11.9.1 Sysmex Corporation Company Details 11.9.2 Sysmex Corporation Business Overview 11.9.3 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.9.4 Sysmex Corporation Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.9.5 Sysmex Corporation Recent Developments 11.10 Buhlmann Laboratories AG 11.10.1 Buhlmann Laboratories AG Company Details 11.10.2 Buhlmann Laboratories AG Business Overview 11.10.3 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Introduction 11.10.4 Buhlmann Laboratories AG Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) 11.10.5 Buhlmann Laboratories AG Recent Developments12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer